# Daewoong Pharmaceutical glucose management initiatives

> Live situation record from CLSTR: https://clstr.news/situations/daewoong-pharmaceutical-glucose-management-initiatives
> Updated: 2026-09-15T00:38:19.000Z. Sources: 6. Developments: 2.

Daewoong Pharmaceutical has expanded its involvement in blood glucose management through public health initiatives and professional medical education.

In late August, the company was selected as a partner for the Seoul Metropolitan Government’s ‘Blood Glucose Catch 9988’ project. This program targets 1,000 pre-diabetic citizens, providing them with continuous glucose monitoring (CGM) devices and lifestyle management services via the ‘Welda’ platform to encourage healthy habits.

Following this, in mid-September, Daewoong Pharmaceutical announced a web symposium titled ‘Shift in Blood Glucose Management Paradigm.’ The event brings together medical experts from South Korea and Japan to discuss clinical trends in CGM technology. The symposium focuses on ‘behavior change,’ emphasizing how continuous glucose data can help patients make daily adjustments to diet, exercise, and medication adherence.

## Claims

- Daewoong Pharmaceutical is hosting a web symposium on the 16th titled ‘Shift in Blood Glucose Management Paradigm’. (corroborated by 3 sources)
- The symposium aims to share the latest clinical trends in diabetes management using Continuous Glucose Monitoring (CGM). (corroborated by 3 sources)
- Professor Mototsugu Nagao of Tokyo Women's Medical University will present on building a new model of diabetes care using CGM. (corroborated by 3 sources)
- Professor Min Se-hee of Seoul Asan Medical Center will discuss FDA-recommended integrated Continuous Glucose Monitoring (iCGM) guidelines. (corroborated by 3 sources)
- Professor Choi Seong-hee of Bundang Seoul National University Hospital will act as the moderator for the symposium. (corroborated by 3 sources)
- The symposium focuses on using CGM data to drive patient behavior changes in diet, exercise, and medication. (corroborated by 3 sources)

## Timeline

### 2026-09-15: Daewoong Pharmaceutical to host symposium on CGM-based diabetes management

Daewoong Pharmaceutical is hosting a web symposium on the 16th featuring Korean and Japanese experts to discuss the latest trends in diabetes management using Continuous Glucose Monitoring (CGM).

5 sources. https://clstr.news/cluster/daewoong-pharmaceutical-to-host-symposium-on-cgm-based-diabetes-management

### 2026-08-26: Daewoong Pharmaceutical to support Seoul blood glucose management project

Daewoong Pharmaceutical will partner with the Seoul Metropolitan Government to provide continuous glucose monitoring and lifestyle management services to 1,000 pre-diabetic citizens.

2 sources. https://clstr.news/cluster/daewoong-pharmaceutical-to-support-seoul-blood-glucose-management-project

---
Cite as: Daewoong Pharmaceutical glucose management initiatives. CLSTR, https://clstr.news/situations/daewoong-pharmaceutical-glucose-management-initiatives